HSE Drugs Group recommends not funding Friedreich’s Ataxia drug episode artwork

EPISODE · Aug 11, 2026 · 7 MIN

HSE Drugs Group recommends not funding Friedreich’s Ataxia drug

from The Hard Shoulder

The HSE Drugs Group has decided to recommend not funding the drug Skyclarys for the rare condition Friedreich's Ataxia. Around 200 people have this disease in Ireland.Pádraig O'Sullivan is Fianna Fáil TD for Cork North Central and joins Shane to discuss.

Episode metadata supplied by the publisher feed · Published Aug 11, 2026

Embed this episode

NOW PLAYING

HSE Drugs Group recommends not funding Friedreich’s Ataxia drug

0:00 7:45

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Hard Shoulder?

This episode is 7 minutes long.

When was this The Hard Shoulder episode published?

This episode was published on August 11, 2026.

Can I download this The Hard Shoulder episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!